# | Timing | Respondents | Data collected |
---|---|---|---|
Q1 | Beginning of step 1 | Public | Public representatives' sociodemographic data (age, gender, ethnic group, language, education, socioeconomic status, health status, health services use, prior attitude toward public involvement) |
Q2 | End of step 1 | Public | Quality-indicators prioritisation (public baseline priorities) |
Q3 | End of step 1 | Public | Participants' evaluation of the step 1 meeting |
Q4 | Step 2 and step 3 meetings | Clinicians and managers | Clinicians and managers' sociodemographic data (age, gender, ethnic group, language, education, socioeconomic status, professional role, prior attitude toward public involvement) |
Q5 | Beginning of step 2 | Clinicians and managers | Quality-indicator prioritisation (clinicians and managers' baseline priorities) |
Q6 | End of step 2 | Clinicians, managers, and public representatives | Quality-indicator prioritisation (postdeliberation priorities) |
Q7 | End of step 2 | Clinicians, managers, and public representatives | Participants' evaluation of the step 2 meeting |
Q8 | End of step 3 | Clinicians, managers, and public representatives | Quality-indicator prioritisation, attitude and intention to use the selected indicators for quality improvement (decision makers' choice and intention to use) |
Q9 | End of step 3 | Clinicians and managers (control sites only) | Quality-indicator prioritisation (postconsultation priorities); this questionnaire is completed after we collect data on decision makers' choice and intention to use, and after we present results of public consultation to control sites |
Q10 | End of step 3 | Clinicians, managers, and public representatives | Participants' evaluation of the step 3 meeting |